158 related articles for article (PubMed ID: 27138904)
21. Driving Neuronal Differentiation through Reversal of an ERK1/2-miR-124-SOX9 Axis Abrogates Glioblastoma Aggressiveness.
Sabelström H; Petri R; Shchors K; Jandial R; Schmidt C; Sacheva R; Masic S; Yuan E; Fenster T; Martinez M; Saxena S; Nicolaides TP; Ilkhanizadeh S; Berger MS; Snyder EY; Weiss WA; Jakobsson J; Persson AI
Cell Rep; 2019 Aug; 28(8):2064-2079.e11. PubMed ID: 31433983
[TBL] [Abstract][Full Text] [Related]
22. Sulforaphane suppresses the growth of glioblastoma cells, glioblastoma stem cell-like spheroids, and tumor xenografts through multiple cell signaling pathways.
Bijangi-Vishehsaraei K; Reza Saadatzadeh M; Wang H; Nguyen A; Kamocka MM; Cai W; Cohen-Gadol AA; Halum SL; Sarkaria JN; Pollok KE; Safa AR
J Neurosurg; 2017 Dec; 127(6):1219-1230. PubMed ID: 28059653
[TBL] [Abstract][Full Text] [Related]
23. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts.
Fan X; Khaki L; Zhu TS; Soules ME; Talsma CE; Gul N; Koh C; Zhang J; Li YM; Maciaczyk J; Nikkhah G; Dimeco F; Piccirillo S; Vescovi AL; Eberhart CG
Stem Cells; 2010 Jan; 28(1):5-16. PubMed ID: 19904829
[TBL] [Abstract][Full Text] [Related]
24. Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism.
Phillips E; Lang V; Bohlen J; Bethke F; Puccio L; Tichy D; Herold-Mende C; Hielscher T; Lichter P; Goidts V
Int J Cancer; 2016 Oct; 139(8):1776-87. PubMed ID: 27299852
[TBL] [Abstract][Full Text] [Related]
25. A growth-promoting signaling component cyclin D1 in neural stem cells has antiastrogliogenic function to execute self-renewal.
Bizen N; Inoue T; Shimizu T; Tabu K; Kagawa T; Taga T
Stem Cells; 2014 Jun; 32(6):1602-15. PubMed ID: 24302516
[TBL] [Abstract][Full Text] [Related]
26. Dissecting biological activities of fibroblast growth factor receptors by the coiled-coil-mediated oligomerization of FGF1.
Porebska N; Pozniak M; Krzyscik MA; Knapik A; Czyrek A; Kucinska M; Jastrzebski K; Zakrzewska M; Otlewski J; Opalinski L
Int J Biol Macromol; 2021 Jun; 180():470-483. PubMed ID: 33745974
[TBL] [Abstract][Full Text] [Related]
27. Novel cross-talk between three cardiovascular regulators: thrombin cleavage fragment of Jagged1 induces fibroblast growth factor 1 expression and release.
Duarte M; Kolev V; Kacer D; Mouta-Bellum C; Soldi R; Graziani I; Kirov A; Friesel R; Liaw L; Small D; Verdi J; Maciag T; Prudovsky I
Mol Biol Cell; 2008 Nov; 19(11):4863-74. PubMed ID: 18784255
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.
Bier A; Giladi N; Kronfeld N; Lee HK; Cazacu S; Finniss S; Xiang C; Poisson L; deCarvalho AC; Slavin S; Jacoby E; Yalon M; Toren A; Mikkelsen T; Brodie C
Oncotarget; 2013 May; 4(5):665-76. PubMed ID: 23714687
[TBL] [Abstract][Full Text] [Related]
29. MELK-dependent FOXM1 phosphorylation is essential for proliferation of glioma stem cells.
Joshi K; Banasavadi-Siddegowda Y; Mo X; Kim SH; Mao P; Kig C; Nardini D; Sobol RW; Chow LM; Kornblum HI; Waclaw R; Beullens M; Nakano I
Stem Cells; 2013 Jun; 31(6):1051-63. PubMed ID: 23404835
[TBL] [Abstract][Full Text] [Related]
30. CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiforme.
Daniele S; La Pietra V; Piccarducci R; Pietrobono D; Cavallini C; D'Amore VM; Cerofolini L; Giuntini S; Russomanno P; Puxeddu M; Nalli M; Pedrini M; Fragai M; Luchinat C; Novellino E; Taliani S; La Regina G; Silvestri R; Martini C; Marinelli L
Eur J Pharmacol; 2021 Apr; 897():173936. PubMed ID: 33581134
[TBL] [Abstract][Full Text] [Related]
31. MERTK Inhibition Induces Polyploidy and Promotes Cell Death and Cellular Senescence in Glioblastoma Multiforme.
Sufit A; Lee-Sherick AB; DeRyckere D; Rupji M; Dwivedi B; Varella-Garcia M; Pierce AM; Kowalski J; Wang X; Frye SV; Earp HS; Keating AK; Graham DK
PLoS One; 2016; 11(10):e0165107. PubMed ID: 27783662
[TBL] [Abstract][Full Text] [Related]
32. A novel fibroblast growth factor-1 (FGF1) mutant that acts as an FGF antagonist.
Yamaji S; Saegusa J; Ieguchi K; Fujita M; Mori S; Takada YK; Takada Y
PLoS One; 2010 Apr; 5(4):e10273. PubMed ID: 20422052
[TBL] [Abstract][Full Text] [Related]
33. Fibroblast growth factor-2-mediated FGFR/Erk signaling supports maintenance of cancer stem-like cells in esophageal squamous cell carcinoma.
Maehara O; Suda G; Natsuizaka M; Ohnishi S; Komatsu Y; Sato F; Nakai M; Sho T; Morikawa K; Ogawa K; Shimazaki T; Kimura M; Asano A; Fujimoto Y; Ohashi S; Kagawa S; Kinugasa H; Naganuma S; Whelan KA; Nakagawa H; Nakagawa K; Takeda H; Sakamoto N
Carcinogenesis; 2017 Oct; 38(11):1073-1083. PubMed ID: 28927233
[TBL] [Abstract][Full Text] [Related]
34. FGF Signalling in the Self-Renewal of Colon Cancer Organoids.
Otte J; Dizdar L; Behrens B; Goering W; Knoefel WT; Wruck W; Stoecklein NH; Adjaye J
Sci Rep; 2019 Nov; 9(1):17365. PubMed ID: 31758153
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the neuropoietic activity of gene-modified versus parental mesenchymal stromal cells and the identification of soluble and extracellular matrix-related neuropoietic mediators.
Aizman I; Tirumalashetty BJ; McGrogan M; Case CC
Stem Cell Res Ther; 2014 Feb; 5(1):29. PubMed ID: 24572070
[TBL] [Abstract][Full Text] [Related]
36. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
[TBL] [Abstract][Full Text] [Related]
37. A global transcriptome analysis reveals molecular hallmarks of neural stem cell death, survival, and differentiation in response to partial FGF-2 and EGF deprivation.
Nieto-Estévez V; Pignatelli J; Araúzo-Bravo MJ; Hurtado-Chong A; Vicario-Abejón C
PLoS One; 2013; 8(1):e53594. PubMed ID: 23308259
[TBL] [Abstract][Full Text] [Related]
38. Aurora A plays a dual role in migration and survival of human glioblastoma cells according to the CXCL12 concentration.
Willems E; Dedobbeleer M; Digregorio M; Lombard A; Goffart N; Lumapat PN; Lambert J; Van den Ackerveken P; Szpakowska M; Chevigné A; Scholtes F; Rogister B
Oncogene; 2019 Jan; 38(1):73-87. PubMed ID: 30082913
[TBL] [Abstract][Full Text] [Related]
39. RasGAP Shields Akt from Deactivating Phosphatases in Fibroblast Growth Factor Signaling but Loses This Ability Once Cleaved by Caspase-3.
Cailliau K; Lescuyer A; Burnol AF; Cuesta-Marbán Á; Widmann C; Browaeys-Poly E
J Biol Chem; 2015 Aug; 290(32):19653-65. PubMed ID: 26109071
[TBL] [Abstract][Full Text] [Related]
40. Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo.
Signore M; Pelacchi F; di Martino S; Runci D; Biffoni M; Giannetti S; Morgante L; De Majo M; Petricoin EF; Stancato L; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
Cell Death Dis; 2014 May; 5(5):e1223. PubMed ID: 24810059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
